What is it about?
This manuscript discusses whether or not chronic inflammatory bowel disease patients can stop or de-escalate immunosuppressive treatment.
Featured Image
Why is it important?
Anti-TNF agents are the most efficacious therapy for Crohn's disease, while they may cause an increased risk of infections and cancers. Therefore, it would be very helpful if we can identify patients who do not need these drugs anymore once achieving remission.
Perspectives
It may not be reasonable for patients with such a chronically progressive disease to stop the therapy which was effective to achieve remission, regardless of their current status.
Taku Kobayashi
Kitasato University Kitasato Institute Hospital
Read the Original
This page is a summary of: Stopping Anti-TNF in CD Remitters: Cons, Inflammatory Intestinal Diseases, August 2021, Karger Publishers,
DOI: 10.1159/000517961.
You can read the full text:
Contributors
The following have contributed to this page
